PISCATAWAY, N.J., July 16, 2007 - Sabinsa Corporation today confirmed that company president Todd Norton will formally participate in the 2007 NBJ/Newport Summit, to be held July 18-20 in Dana Point, Calif.
Mr. Norton will serve as a guest panelist for the discussion, "Case Studies in Capturing Healthcare Dollars and Healthcare Prevention" on Thursday, July 19. Specifically, he will highlight the value of creating intellectual property including branding opportunities and return on investments, as well as discuss the challenges associated with promoting and protecting intellectual property in the global marketplace.
"If as an industry we want to continue to encourage companies to invest significant time and resources into developing intellectual property, then we need to come together and support them in the protection of that intellectual property," said Norton. "There needs to be an industry commitment to passing on ingredients and products that are clearly infringing, rather than just leaving up to the individual company who created that intellectual property to protect it."
Sabinsa representatives will also be on hand to accept their Nutrition Business Journal Business Achievement Awards announced earlier this year. NBJ recognized the company with a merit award for their branded ingredient GarliSelect(R) and a scientific achievement award for Curcumin C3 Complex(R). This is the third year that Sabinsa has been recognized by NBJ for its distinguished achievements in various business categories within the natural products industry.
Marking its tenth year, the 2007 NBJ/Newport Summit brings together leaders and innovators from the natural products industry to discuss challenges, share experiences and develop more effective strategies to respond to consumer needs.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information, visit www.sabinsa.com.
# # #